Sabby Management, LLC Oragenics Inc Transaction History

Sabby Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$0.43 - $0.75 $150,949 - $263,283	-351,045 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$0.42 - $0.62 $112,466 - $166,021	-267,777 Reduced 43.27%	351,045 $184,000
Q3 2019 Nov 15, 2019	SELL	$0.36 - $0.64 $230,583 - $409,927	-640,511 Reduced 50.86%	618,822 $334,000
Q2 2019 Aug 14, 2019	BUY	$0.46 - $0.6 $344,380 - $449,192	748,654 Added 146.6%	1,259,333 $617,000
Q1 2019 May 15, 2019	BUY	$0.57 - $1.05 $291,087 - $536,212	510,679 New	510,679 $299,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.